Impact of vaccine type on HIV-1 vaccine elicited antibody durability and B cell gene signature.

MLA

Palli, Rohith, et al. “Impact of Vaccine Type on HIV-1 Vaccine Elicited Antibody Durability and B Cell Gene Signature.” Scientific Reports, vol. 10, no. 1, Aug. 2020, pp. 1–15. EBSCOhost, https://doi.org/10.1038/s41598-020-69007-w.

APA

Palli, R., Seaton, K. E., Piepenbrink, M. S., Hural, J., Goepfert, P. A., Laher, F., Buchbinder, S. P., Churchyard, G., Gray, G. E., Robinson, H. L., Huang, Y., Janes, H., Kobie, J. J., Keefer, M. C., Tomaras, G. D., & Thakar, J. (2020). Impact of vaccine type on HIV-1 vaccine elicited antibody durability and B cell gene signature. Scientific Reports, 10(1), 1–15. https://doi.org/10.1038/s41598-020-69007-w

Chicago

Palli, Rohith, Kelly E. Seaton, Michael S. Piepenbrink, John Hural, Paul A. Goepfert, Fatima Laher, Susan P. Buchbinder, et al. 2020. “Impact of Vaccine Type on HIV-1 Vaccine Elicited Antibody Durability and B Cell Gene Signature.” Scientific Reports 10 (1): 1–15. doi:10.1038/s41598-020-69007-w.